STATEMENT OF NEED
Advanced-stage cancers, including lung, breast, prostate, and multiple myeloma, can have a detrimental effect on bone health (Coleman, Croucher et al, 2020). Once cancer spreads to the skeletal system, the risk for pain, fractures, hypercalcemia, and spinal cord compression increases considerably (Coleman, Hadji et al, 2020). The management of bone metastases requires a multidisciplinary approach with prompt detection and treatment, as delayed treatment is associated with detrimental effects on patients’ overall survival and quality of life (Migliorini et al, 2020; Southcott et al, 2020). As nurses are often the first to assess patients presenting with bone metastases, the role of the oncology nursing team is crucial to their management. This activity will update oncology nurses on the pathophysiology of bone metastases, patient- and treatment-related factors that put patients at risk, and strategies for managing bone complications to optimize outcomes for patients with cancer.
Oncology nurses, nurse practitioners, clinical nurse specialists, and other health care professionals involved in the treatment of patients with cancer.
Upon completion of this activity, participants should be able to:
i3 Health is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1.0 contact hour may be earned by learners who successfully complete this NCPD activity.
Provider approved by the California Board of Registered Nursing, Provider Number 15824, for 1.0 contact hour.
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.
ONCC review is only for designating content to be used for recertification points and is not for NCPD accreditation. NCPD programs must be formally approved for contact hours by an acceptable accreditor/approver of NCPD to be used for recertification by ONCC. If the NCPD provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification may be used in relation to the program.
OCN®, CPHON®, CBCN®, AOCNP®, AOCNS®, and BMTCN® renewal candidates may apply 1 ILNA point toward:
Please note that some of the course content applies to multiple content areas. The numerical value above indicates the maximum amount of points that can be claimed in each domain. The total amount of ILNA points claimed may not exceed the total amount of NCPD awarded from this course.
REQUIREMENTS FOR CREDIT
To claim your NCPD certificate for this activity, please complete the following steps:
TECHNOLOGY REQUIREMENTS FOR VIRTUAL CME | NCPD | CPE ACTIVITIES
For virtual (asynchronous, archived live, home study; synchronous webinars) CME/NCPD/CE activities, include access to system requirements:
No prerequisites are required for this activity.
Relevant financial relationships exist between the following individuals and commercial interests:
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS WITH INELIGIBLE COMPANIES
i3 Health endorses the standards of the ANCC that require everyone in a position to control the content of a NCPD activity to disclose all financial relationships with ineligible companies that are related to the content of the NCPD activity. NCPD activities must be balanced, independent of commercial bias, and promote improvements or quality in health care. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.
A conflict of interest is created when an individual has an opportunity to affect NCPD content about products or services of a commercial interest with which he/she has a financial relationship, which therefore may bias their opinions and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks, or other financial benefits.
i3 Health will identify, review, and mitigate all conflicts of interest that speakers, authors, or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. i3 Health does not endorse any products or services.
UNAPPROVED USE DISCLOSURE
i3 Health requires NCPD faculty to disclose to participants when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved), as well as any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty will not discuss information about pharmaceutical agents that is outside of FDA approved labeling. This information is intended solely for educational purposes and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
The information provided in this NCPD activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.